BioQ Pharma Incorporated, a San Francisco, CA-based specialty pharmaceutical company, secured new financing of up to $55m.
Madryn Asset Management, LP, an alternative asset management firm focused on investments in innovative healthcare companies, provided the financing.
The company intends to use the proceeds from the investment to expand existing commercial operations, support anticipated near-term regulatory approvals, and advance earlier-stage development activities.
Led by Josh Krisel, Chief Executive Officer, BioQ is focused on the development and commercialization of ready-to-use infusible pharmaceutical and biological products that can be deployed quickly at the point of care.
The company, ISO13485 certified, has commercial collaborators and strategic partners including Novartis’ Sandoz unit, Cipla, Lee’s Pharm, Lunatus, Galen Limited, Pharma Mart, and West Pharmaceutical Services.